The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus, evidence-based recommendations to aid in the design, validation ...
Genotyping tool is designed to detect genotypes related to 2C9*2, 2C9*3, and VKORC1 from a buccal swab. Mayo Clinic inked a deal with Rheonix to assess the performance of the company’s genotyping test ...
This is kind of an interesting project. I know warfarin sensitivity is a big deal in the med community, so this could a significant deal Mayo Medical Laboratories announced Monday that it is ...
ROCKVILLE, Md. - May 5, 2020 - The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus, evidence-based recommendations ...
WASHINGTON (March 19, 2017) - Using genetic testing to help personalize doses of warfarin therapy given to patients undergoing elective orthopedic surgery appears to lower the risk of combined adverse ...
Researchers have discovered a simple genetic test that helps doctors determine the best dose of the blood-thinner drug warfarin for individual patients could reduce hospitalizations by one-third ...
ATLANTA (Reuters) - Use of genetic screening on heart patients helped cut hospitalizations related to the widely used blood thinner warfarin by nearly a third, according to a large study that marks a ...
Northbrook, Ill - The US FDA has approved a new genetic test to help assess warfarin sensitivity [1]. The FDA notes that one-third of patients metabolize warfarin more slowly than others and therefore ...
Deviation from Hardy-Weinberg equilibrium has become an accepted test for genotyping error. While it is generally considered that testing departures from Hardy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback